Skip to main content
Top

Calcified Tissue International

Issue 5/1997

Content (18 Articles)

Bone Modeling Indexes at Onset and During the First Year of Follow-Up in Insulin-Dependent Diabetic Children

R. Bonfanti, S. Mora, C. Prinster, E. Bognetti, F. Meschi, M. Puzzovio, M. C. Proverbio, G. Chiumello

Antiresorptive Effect of a Single Infusion of Microgram Quantities of Zoledronate in Paget's Disease of Bone

M. Arden-Cordone, E. S. Siris, K. W. Lyles, A. Knieriem, R. A. Newton, V. Schaffer, K. Zelenakas

Diurnal Variation of Bone Mineral Turnover in Elderly Men and Women

S. L. Greenspan, R. Dresner-Pollak, R. A. Parker, D. London, L. Ferguson

Influence of Spondylopathy on Bone Densitometry Using Dual Energy X-Ray Absorptiometry

S. Jaovisidha, D. J. Sartoris, E. M. E. Martin, M. De Maeseneer, S. M. Szollar, L. J. Deftos

Impact of Spinal Degenerative Changes on the Evaluation of Bone Mineral Density with Dual Energy X-Ray Absorptiometry (DXA)

Th. Rand, G. Seidl, F. Kainberger, A. Resch, K. Hittmair, B. Schneider, C. C. Glüer, H. Imhof

Prevalence of Trabecular Microcallus Formation in the Vertebral Body and the Femoral Neck

X. G. Cheng, P. H. F. Nicholson, G. Lowet, S. Boonen, Y. Sun, P. Rüegsegger, R. Müller, J. Dequeker

The Metabolism of Vitamin D3 in Response to Testosterone

I. Otremski, M. Lev-Ran, R. Salama, S. Edelstein

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine